Efevre Tech LTD

14/05/2026

Can my cat give me hantavirus?
Is it airborne or only from bites?
How deadly is it, really?

People ask these questions every day. The answers exist in the peer-reviewed literature. Scattered across dozens of papers. Behind paywalls. Written for specialists.

We ran the full synthesis on BioSkepsis — 15 verified PMIDs, every claim grounded to source, unverified citations flagged transparently.

Here's what the evidence actually says:
➡️ Transmission is primarily airborne — inhaling dust from dried rodent urine/feces, not bites
➡️ Hantavirus Pulmonary Syndrome kills 35–50% of patients in the Americas
➡️ There is no vaccine. No antiviral. Survival depends on early intensive care
➡️ Cats are dead-end hosts — but they bring infected rodents into your house
➡️ The single most effective prevention: wet contaminated surfaces before cleaning. That's it.

No hedging. No hallucinated citations. No "consult your doctor" cop-out where a PMID would do.

🔗 Full research thread: https://bioskepsis.ai/blog/hantavirus-transmission

30/04/2026

📲 Your free upgrade is calling!

We are offering a 𝟱𝟬% 𝗢𝗙𝗙 discount on our 𝗣𝗿𝗼 𝗣𝗮𝗰𝗸𝗮𝗴𝗲 for 𝟯 𝗳𝘂𝗹𝗹 𝗺𝗼𝗻𝘁𝗵𝘀. But there's a catch... It’s only for the first 20 legends who are quick enough to grab it!

Will you be one of them? 🏃💨

🔗 https://app.bioskepsis.ai/?utm_source=socialmedia&utm_medium=promo&utm_campaign=launch50pro

09/04/2026

From unlimited hours of manual work to under 5 minutes hands-free.

We built Autopilot Mode because researchers shouldn't have to choose between manually finding papers nor waste time instructing AI tools.

Type your question. Let Autopilot read your research intent, build a targeted search strategy, run all queries in parallel, screen out irrelevant sources, and deliver you your first in-depth analysis — all while you focus on what actually matters.

The literature is vast. The questions never stop. And the time to find the right answers has always been the bottleneck ... Until now!

Swipe the slides to see how Autopilot changes things 👉

🔗 Full breakdown in the blog: https://bioskepsis.ai/blog/autopilot-mode

02/04/2026

Scientific fields are built on a small number of landmark studies. Most researchers never encounter them directly.

BioSkepsis AI surfaces Foundational Papers: These are the landmark studies at the center of your field's citation network, identified automatically within any research query. Each Foundational Paper comes with a full breakdown of experimental models, key findings, limitations the original authors flagged, and the studies that followed.

🧑‍🔬 For Early Career Researchers, this means your thesis argumentation is grounded in verified primary evidence rather than secondary citations.
👨‍💻 For Consultants this means you can know exactly where the science in your field actually starts with a rigorous cross-checking mechanism, ensuring the claims of the scientific argument are robust.

Watch it in action [starting at 1:43 ] ➡️ https://youtu.be/MMTLO9Euhsk?si=XUu_bhtkIr7OKyXy
Full breakdown on the blog ➡️ https://bioskepsis.ai/blog/foundational-papers

30/03/2026

Today, EFEVRE TECH LTD had the privilege of attending the Cyprus–Greece High Technology and Innovation Conference, organized by Cyprus Chamber of Commerce & Industry, the Cyprus Embassy Trade Center in Athens, and the Σύνδεσμος Κυπρίων Επαγγελματιών Ελλάδας (ΣΚΕΕ) - Association of Cypriot Professionals in Greece.

We're grateful to Philokypros Roussounides (Secretary General, CCCI), Stavros Avgoustides (Ambassador of the Republic Of Cyprus), Despina Panayiotou Theodosiou (President of ΣΚΕΕ), Stalo Demosthenous (Director and Department of Services of CCCI), and the entire organizing team for the invitation and for bringing together such a remarkable network of innovators and decision-makers.

A special thank you to the companies who took the time to connect with us and showed interest towards our work:
🔬 DNANUTRICOACH® - Applied Nutrigenetics - Food is medicine & prevention is a lifestyle. – Dr. Valentini Konstantinidou
💳 Quality & Reliability S.A. (QnR) – Eleftherios Koutsoloukas
🎓 European Hub of Education – George Goutzianas
💻 DOTSOFT SA – Stavros Katsaridis
⚓ DockYard, Inc. – Paraskevi Petridou
🔬 Scientific Enterprises Limited – spiros karagiorgos

We look forward to exploring what we can build together. 🚀

27/03/2026

The Endless Paper Problem 🔬
Save your eyes (and your sanity) 😅

We’ve developed a precise solution for the modern scientist who wants to go above and beyond. With BioSkepsis, you can:
🔎 Know instantly if your laboratory result actually means something
💭 Find the papers that support your hypothesis in just a few minutes
📈 Design your research under a clear light of the literature

Stop reading 200 papers just to find one answer.

Discover how BioSkepsis can reclaim your time and maximize your research.

24/03/2026

Your Zotero library is a goldmine with years of curated papers. Stop treating it like a graveyard.

𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐢𝐧𝐠 𝐋𝐢𝐛𝐫𝐚𝐫𝐲 𝐈𝐦𝐩𝐨𝐫𝐭! Your Zotero library reflects your expertise; BioSkepsis AI gives it a brain. Link your collections to import up to 1,000 papers securely. The platform then automatically adds the latest relevant research, ensuring your session is grounded in the literature you trust and expanded by the literature you need.

🧑‍🔬 Early-Career Researchers for thesis literature collection
👨‍💻 Biomedical and Pharma for workflow evaluation
🧑‍⚕️ Pharmacovigilance for curated evidence on adverse events

See the full demo on YouTube [starting at 1:10] ➡️ https://youtu.be/MMTLO9Euhsk?si=0cPkS4V4APto71Ik
Read the full blog on BioSkepsis Website ➡️ https://bioskepsis.ai/blog/zotero-library-connection

18/03/2026

Are you a Principal Investigator trying to keep your team aligned across multiple research directions at once? A lecturer managing literature across ten different course modules? Or part of a biomedical team where staying current with the evidence base is a daily operational challenge?

We just launched the Research Feed: A new feature inside BioSkepsis AI that delivers a continuously updated, personalised stream of the most relevant biomedical publications directly to your dashboard.

Unlike generic journal alerts, the Research Feed is semantically driven. It ranks new publications by their biological and conceptual proximity to your active research topics. You can organise your topics into folders, share feeds with your team, and ensure that no mechanistically significant finding goes unnoticed. Enable your Research Digest to never want to miss an update.

🎬 What this video shows:
Watch the video to learn how the Research Feed works inside BioSkepsis — from setting up your personalised topic folders to reviewing newly surfaced publications in real time and enabling your Research Digest email alerts.

Watch the full YouTube video ➡️ https://youtu.be/MMTLO9Euhsk?si=MFICgku2D8cPP9hZ

18/03/2026

Plot Twist: There are actual humans behind BioSkepsis

Meet the team behind BioSkepsis AI, the people making biomedical literature a little less overwhelming (and a lot more searchable).

Say hi 👋
🔗 https://youtu.be/YlArA89GWgg?si=ju30WL2nN7MsJdbS

13/03/2026

POV: You are 3 weeks from your literature review deadline and your hypothesis document is still blank 💀

Your next hypothesis is one click away — and it's 𝑭𝑹𝑬𝑬.

If you're a PhD Student/Candidate, PostDoc, or Early-Career Researcher drowning in literature reviews and staring at blank grant pages, Research Hub was built for you.

🧬 Ready-to-go hypotheses for your reviews and summaries
🔬 Molecular pathways for major diseases
💡 Advanced experimental methods to test your hypothesis

Join for free 👉 bioskepsis.ai/hub

11/03/2026

In Pharmacovigilance, "more data" has shifted from a goal to an operational strain. For today's Program Leads, the real risk isn't just the data — it’s the latency between a signal appearing and an action being taken.

BioSkepsis AI is designed to shift the burden by:
📶 Rapidly validate signals across biomedical literature.
📋 Enhance risk-benefit profiling for more robust regulatory submissions.
✍️ Validate safety findings against real-world evidence and published data.

The future isn’t about hiring more people to scroll through more papers of data; it’s about empowering your experts with the precision of BioSkepsis AI.

📌 Learn More :
Visit BioSkepsis AI ➡️ bioskepsis.ai
Visit EFEVRE TECH LTD ➡️ efevre.com
Contact us at ➡️ [email protected]

Watch the full YouTube video here 👉 https://youtu.be/vjdg1WiovmA?si=51EbD6fNQagGGVnX

This demo shows how BioSkepsis AI helps drug safety teams understand whether a medicine may cause side effects and how serious those risks are.🧑‍🔬 BioSkeps...